Literature DB >> 15385386

A patient with Glanzmann's thrombasthenia for emergent abdominal surgery.

Halil Ibrahim Uzunlar1, Ahmet Eroglu, Ahmet Can Senel, Habib Bostan, Nesrin Erciyes.   

Abstract

Glanzmann's thrombasthenia is a rare autosomal recessive disease characterized by potentially major mucocutaneous complications and nose bleeds. It is considered hazardous for these surgical patients to conceive, with a high risk of urgent surgery. The treatment of bleeding or prevention of hemorrhage for surgery or invasive procedures is based on platelet transfusion. However, platelet transfusions may be responsible for the development of alloimmunization, with a high risk of future platelet refractoriness. We report a surgical case of Glanzmann's thrombasthenia complicated by nasopharyngeal bleeding and managed with platelet transfusions, recombinant activated factor VII, and postoperative airway management in the intensive care unit.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385386     DOI: 10.1213/01.ANE.0000131726.09685.BF

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

1.  Surgical treatment of cecal cancer in a patient with Glanzmann's thrombasthenia: report of a case.

Authors:  Akira Kabashima; Naoyuki Ueda; Yusuke Yonemura; Kojiro Mashino; Kyuzo Fujii; Tetsuo Ikeda; Hideya Tashiro; Hisanobu Sakata
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

2.  Anaesthetic Management with Thromboelastography in a Patient with Glanzmann Thrombasthenia.

Authors:  Ahmet Topal; Alper Kılıçaslan; Atilla Erol; Barış Çankaya; Şeref Otelcioğlu
Journal:  Turk J Anaesthesiol Reanim       Date:  2014-05-29

3.  Emergency craniotomy in Glanzmann thrombasthenia: Anesthetic management and brief review of literature.

Authors:  Devi Prasad Dash; Abhuday Kumar; Babita Gupta
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2016 Oct-Dec

Review 4.  Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia.

Authors:  Man-Chiu Poon
Journal:  Vasc Health Risk Manag       Date:  2007
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.